Education
About Us
Working with TipRanks
Follow Us
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
Technical Sentiment
Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
BridgeBio Oncology Therapeutics’s (BBOT) Moving Averages Convergence Divergence (MACD) indicator is -0.48, suggesting BridgeBio Oncology Therapeutics is a Buy.
BridgeBio Oncology Therapeutics’s (BBOT) 20-Day exponential moving average is 10.73, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 50-Day exponential moving average is 11.32, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics (BBOT) Pivot Points
Classic
9.43
9.69
9.86
10.12
10.29
10.55
10.72
Fibonacci
9.69
9.85
9.96
10.12
10.28
10.39
10.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
BridgeBio Oncology Therapeutics (BBOT) Moving Averages
MA5
10.20Sell
10.17Sell
MA10
10.26Sell
10.35Sell
MA20
10.76Sell
10.73Sell
MA50
11.61Sell
11.32Sell
MA100
11.84Sell
11.49Sell
MA200
11.23Sell
11.22Sell
BridgeBio Oncology Therapeutics’s (BBOT) 10-Day exponential moving average is 10.35, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) 100-Day exponential moving average is 11.49, while BridgeBio Oncology Therapeutics’s (BBOT) share price is $12.59, making it a Sell.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 50-day simple moving average is 11.61, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 100-day simple moving average is 11.84, creating a Sell signal.
BridgeBio Oncology Therapeutics’s (BBOT) stock price is $12.59 and BridgeBio Oncology Therapeutics’s (BBOT) 200-day simple moving average is 11.23, creating a Sell signal.
BridgeBio Oncology Therapeutics (BBOT) Technical Indicators
RSI (14)
40.08
Neutral
STOCH (9,6)
23.28
Neutral
STOCHRSI (14)
16.38
Buy
MACD (12,26)
-0.48
Buy
ADX (14)
12.44
Buy
Williams %R
-78.79
Buy
CCI (14)
-95.81
Neutral
ATR (14)
0.80
-
Ultimate Oscillator
47.39
Neutral
ROC
-5.62
Sell
BridgeBio Oncology Therapeutics’s (BBOT) Relative Strength Index (RSI) is 40.08, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Trend Strength Indicator (ADX) is 12.44, creating a Buy signal.
BridgeBio Oncology Therapeutics’s (BBOT) Commodity Channel Index (CCI) is -95.81, creating a Neutral signal.
BridgeBio Oncology Therapeutics’s (BBOT) Price Rate of Change (ROC) is -5.62, creating a Sell signal.
FAQ
Is BBOT a Buy, Hold, or Sell?
Based on BBOT’s technical indicators, BBOT is a Sell.
What is BBOT’s RSI (14)?
BBOT’s RSI (14) is 40.08, which suggests BBOT is a Neutral.
What is BBOT’s MACD?
BBOT’s MACD is -0.48, which suggests BBOT is a Buy.
What is BBOT’s 5-day moving average?
BBOT’s 5-day moving average is 10.20, which suggests BBOT is a Sell.
What is BBOT’s 20-day moving average?
BBOT 20-day moving average is 10.76, which suggests BBOT is a Sell.
What is BBOT’s 50-day moving average?
BBOT’s 50-day moving average is 11.61, which suggests BBOT is a Sell.
What is BBOT’s 200-day moving average?
BBOT’s 200-day moving average is 11.23, which suggests BBOT is a Sell.
What is BBOT’s Williams % R (14)?
BBOT’s Williams % R (14) is -78.79, which suggests BBOT is a Buy.
What is BBOT’s CCI (14)?
BBOT’s CCI (14) is -95.81, which suggests BBOT is a Neutral.